Literature DB >> 34088687

Intracranial response after extracranial radiation in a patient with rapidly progressing metastatic melanoma.

Oliver Piercey1, Jonathan Mark Tomaszewski2, Kortnye Smith3,4.   

Abstract

Growing literature supports the synergistic effect of radiation as a primer for renewed enhanced systemic immunological responses in patients receiving immunotherapy for metastatic melanoma. Radiographic regression of extracranial tumours after treatment of intracranial metastatic lesions has been reported and these observations point to an abscopal effect that traverses the blood-brain barrier. We describe a patient with rapidly progressing metastatic melanoma despite combined immune checkpoint blockade, who achieved a complete metabolic response of both his extracranial and intracranial disease after the commencement of palliative radiation to his axilla. This is the first published case, to our knowledge, of a sustained, complete intracranial abscopal response from extracranial radiation. We discuss potential mechanistic relations between radiation, the blood-brain barrier and the abscopal effect. © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  immunology; radiotherapy; skin cancer

Year:  2021        PMID: 34088687     DOI: 10.1136/bcr-2020-240921

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

1.  Differential abscopal effect in extracranial and intracranial lesions after radiotherapy alone for vertebral bone metastasis of unknown primary: a case report.

Authors:  Yojiro Ishikawa; Rei Umezawa; Takaya Yamamoto; Noriyoshi Takahashi; Kazuya Takeda; Yu Suzuki; Keiichi Jingu
Journal:  J Med Case Rep       Date:  2022-03-06

Review 2.  The abscopal effect: systematic review in patients with brain and spine metastases.

Authors:  Dhiraj J Pangal; Benjamin Yarovinsky; Tyler Cardinal; David J Cote; Jacob Ruzevick; Frank J Attenello; Eric L Chang; Jason Ye; Josh Neman; Frances Chow; Gabriel Zada
Journal:  Neurooncol Adv       Date:  2022-08-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.